Role of stereotactic body radiation therapy for hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Role of stereotactic body radiation therapy for hepatocellular carcinoma

Role of stereotactic body radiation therapy for hepatocellular carcinoma

http://www.wikidata.org/entity/Q26864969

about

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26 Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.Charged particles for liver cancer.Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review.Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma: A multicenter analysis in Korea (KROG 14-17)Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity.Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?Defining Radiation-Induced Hepatic Toxicity in Hepatocellular Carcinoma Patients Treated with Stereotactic Body Radiotherapy.Bridging to liver transplantation in HCC patients.Clinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience.Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.

P2860

Q28076314-696D3038-8B0A-4066-B044-C9B7E88F97EA Q36249520-A1187A5E-70E6-4FBA-89ED-25DAC7B21300 Q36401584-2143CBC4-7482-4CFC-A3F3-9494647D0DB0 Q36430664-B113A22D-6338-48D1-8506-55C9DD74C9BC Q36545796-AB07A463-8ACF-4D66-B7A0-A17299226097 Q36596607-09B3E039-4E27-43DB-A62C-61CB21A63683 Q36949330-16206C73-0C10-4D98-93D3-E4F443789E45 Q38831804-F1782ACA-7EF7-4207-B5CA-4548690A814B Q38938405-D489AF80-5417-4DE6-952E-8532679F636C Q41083736-E9E365E9-CFD0-4C21-8B88-5FAEADDE4DF2 Q42260214-91993C0C-C388-4273-B843-3DB8BE32D9F4 Q42395957-A5E1B4D0-A5BE-42AE-B229-BE17B2426F8B Q47150769-F24B9E1C-641C-49AE-BA01-82F203210D62 Q48326665-A35182F0-3207-4E07-BE49-BEFDB65E6FFE Q49248688-CAF44E19-86A7-42DE-BD9D-6004F3642B60 Q49627926-A8A2B304-D6CC-4BAC-8DD8-958E5F6992E5 Q55237505-08F31A38-D878-40EC-93A6-B6BF7AD4826B

P2860

Role of stereotactic body radiation therapy for hepatocellular carcinoma

http://www.wikidata.org/entity/Q26864969

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@ast

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@en

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@nl

type

label

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@ast

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@en

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@nl

prefLabel

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@ast

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@en

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@nl

P1433

Q26864969-E0D5A9BF-E433-4FA0-B724-277B6C79961F

P1476

Q26864969-CAE8250E-2EF8-41D1-B37B-EDE11092CFBD

P2093

Q26864969-28F4FFD8-32E2-4EBB-9A64-4EF6CC3EAB89

Q26864969-4F4BAAA9-A25E-4F56-85C8-83F46DE2010C

P2860

Q26864969-05756017-A812-4EE3-B21C-D091C1A5B065

Q26864969-0781D46D-DEDC-4DE4-AB2F-062408218918

Q26864969-1CB62DFE-E2E2-40C9-ABDD-48210A477591

Q26864969-2580D62B-59DF-469D-94AD-D0554ED72C18

Q26864969-2C72D67C-198B-4313-A027-9F50BF9F533A

Q26864969-2F74AC25-2F38-4443-976D-D5B116EF2D4A

Q26864969-3219A480-9B9E-4F76-B0FA-E20D50C64171

Q26864969-356EAEA8-3379-4953-80A9-A40DA5D581F2

Q26864969-397B94FB-76A4-4CA4-AF8E-D2BA2E694DDE

Q26864969-3B5D7962-3183-4665-B9AC-7CBDC5F4CC20

P304

Q26864969-F70933BA-4279-4141-B61E-80A7DEC98F42

P31

Q26864969-03B281C1-00FE-4B94-BD84-C8E133803158

P3181

Q26864969-3C24E877-1B40-488C-AD91-18BE58D50CEC

P356

Q26864969-1D0F3DE5-138C-4DDC-83C4-DF51B232A50B

P407

Q26864969-ACE2C186-A349-4B96-B6CE-6DDA9F94636E

P433

Q26864969-1F086809-D748-43B7-87EE-18B5DE7AD3C4

P478

Q26864969-4C9BB59F-B886-47C2-ACD5-95DC59A8D98D

P50

Q26864969-D04BB276-F312-4F47-90F3-7F675199C4D5

P577

Q26864969-3E8FE615-D011-4FFD-A6DE-5678656A88C6

P5875

Q26864969-CEA05A10-CB4C-4F6F-BF4F-3C1414B13783

P698

Q26864969-49450107-DB7E-4B16-ADE5-FA887E208C88

P921

Q26864969-7F59B705-A111-4474-BC56-F213CB02EFC1

P932

Q26864969-B30771E1-9715-44FF-9FC7-287FB1104532

P3181

P356

WJG.V20.I12.3100

P1433

World Journal of Gastroenterology

P1476

Role of stereotactic body radiation therapy for hepatocellular carcinoma

@en

P2093

Atsuya Takeda

http://www.w3.org/2001/XMLSchema#string

Etsuo Kunieda

http://www.w3.org/2001/XMLSchema#string

P2860

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

Charged-particle therapy for hepatocellular carcinoma

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control.

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.

Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis

P304

3100-3111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3293480

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V20.I12.3100

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261329128

http://www.w3.org/2001/XMLSchema#string

P698

24696597

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3964382

http://www.w3.org/2001/XMLSchema#string